Literature DB >> 8228628

Interplay between superantigens and the immune system.

M J Irwin1, N R Gascoigne.   

Abstract

Superantigens interact with the immune system by binding to major histocompatibility complex (MHC) class II proteins and activating T cells through the variable region of the T cell receptor beta-chain. Through this means they can cause massive proliferation and then death of a large proportion of T cells. Superantigens are produced by bacteria, mycoplasmas, retroviruses, and probably by other organisms. In some cases, the superantigen is crucial to the organism's life cycle. Mouse mammary tumor virus disseminates by activating T cells which stimulate the proliferation of B cells harboring the virus. In other cases, the superantigen may be responsible for the pathogenesis of the infection, such as in the case of Toxic Shock Syndrome. In this article, we review information on the diseases in which superantigens are involved, and the mechanisms by which the superantigens interact with T cell receptor and class II molecules.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8228628     DOI: 10.1002/jlb.54.5.495

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  10 in total

Review 1.  Immune response to staphylococcal superantigens.

Authors:  T Krakauer
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Staphylococcal enterotoxin B-induced acute inflammation is inhibited by dexamethasone: important role of CXC chemokines KC and macrophage inflammatory protein 2.

Authors:  Rene Schramm; Henrik Thorlacius
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

3.  Protein kinase C η is required for T cell activation and homeostatic proliferation.

Authors:  Guo Fu; Jianfang Hu; Nathalie Niederberger-Magnenat; Vasily Rybakin; Javier Casas; Pia P Yachi; Stephanie Feldstein; Bo Ma; John A H Hoerter; Jeanette Ampudia; Stephanie Rigaud; Florence Lambolez; Amanda L Gavin; Karsten Sauer; Hilde Cheroutre; Nicholas R J Gascoigne
Journal:  Sci Signal       Date:  2011-12-06       Impact factor: 8.192

Review 4.  Tumor viruses and endogenous retrotransposons in mammary tumorigenesis.

Authors:  B B Asch
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-01       Impact factor: 2.673

5.  Themis controls thymocyte selection through regulation of T cell antigen receptor-mediated signaling.

Authors:  Guo Fu; Sébastien Vallée; Vasily Rybakin; Marielena V McGuire; Jeanette Ampudia; Claudia Brockmeyer; Mogjiborahman Salek; Paul R Fallen; John A H Hoerter; Anil Munshi; Yina H Huang; Jianfang Hu; Howard S Fox; Karsten Sauer; Oreste Acuto; Nicholas R J Gascoigne
Journal:  Nat Immunol       Date:  2009-07-13       Impact factor: 25.606

6.  Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis.

Authors:  M Lopez-Hoyos; M J Bartolome-Pacheco; R Blanco; V Rodriguez-Valverde; V M Martinez-Taboada
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

7.  Cytotoxic activity of V beta 8+ T cells in Crohn's disease: the role of bacterial superantigens.

Authors:  M E Baca-Estrada; D K Wong; K Croitoru
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

8.  CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease.

Authors:  Y Cong; S L Brandwein; R P McCabe; A Lazenby; E H Birkenmeier; J P Sundberg; C O Elson
Journal:  J Exp Med       Date:  1998-03-16       Impact factor: 14.307

9.  Reduced TCR signaling potential impairs negative selection but does not result in autoimmune disease.

Authors:  Sujin Hwang; Ki-Duk Song; Renaud Lesourne; Jan Lee; Julia Pinkhasov; Liqi Li; Dalal El-Khoury; Paul E Love
Journal:  J Exp Med       Date:  2012-09-03       Impact factor: 14.307

10.  Protein kinase D regulates positive selection of CD4+ thymocytes through phosphorylation of SHP-1.

Authors:  Eri Ishikawa; Hidetaka Kosako; Tomoharu Yasuda; Masaki Ohmuraya; Kimi Araki; Tomohiro Kurosaki; Takashi Saito; Sho Yamasaki
Journal:  Nat Commun       Date:  2016-09-27       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.